GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth 
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S. 
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery 
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans 
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns 
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market 
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
Westpac Director Peter Nash Avoids Major Investor Backlash Amid ASX Scrutiny 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Alibaba Group (NYSE:BABA; HK:9988) saw its shares decline on Friday following the announcement of a HK$12 billion ($1.53 billion) zero-coupon exchangeable bond offering tied to its healthcare subsidiary, Alibaba Health Information Technology (HK:0241).
Unveiled on Thursday and priced on Friday, the bonds are exchangeable into Alibaba Health shares at a 48% premium to the company’s recent private placement price of HK$6.23. Investors can convert the bonds into shares beginning on the 41st day after issuance, with a maturity set for 2032.
The move comes as part of Alibaba’s strategy to boost investment in cloud computing infrastructure and global e-commerce operations, areas the tech giant has prioritized amid rising competition in the sector. The offering marks Alibaba’s second significant bond issuance within a year, following a $5 billion dual-currency deal in late 2024.
While the bond deal may support Alibaba’s long-term strategic goals, investors reacted cautiously. Alibaba Group’s Hong Kong-listed shares dropped as much as 3% on Friday, and Alibaba Health shares declined nearly 7%, reflecting concerns over potential equity dilution and market volatility.
This bond issuance underscores Alibaba’s ongoing effort to unlock value from its subsidiaries and raise capital for expansion, even as market sentiment remains sensitive to large-scale financial maneuvers. The company continues to navigate a complex landscape of regulatory shifts, global economic uncertainty, and evolving consumer behavior in both domestic and international markets.
By leveraging Alibaba Health’s equity through premium-linked bonds, the company aims to balance capital efficiency with investor flexibility—though short-term market reactions suggest cautious optimism at best.
